Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis

Neurology

Volumn 76, Issue 15, 2011, Pages 1288-1295

  Tisserand, M ^a   Le Guennec, L ^a   Touze E ^a   Hess, A ^a   Charbonnier, C ^b,c   Devauchelle, A D ^a   Bracard, S ^d   Mas, J L ^a   Meder J F ^a   Oppenheim, C ^a,e  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^b UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^c Department of Diagnostic ^*  (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECENT SILENT ISCHEMIA; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 79954586411     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182152855     Document Type: Article

References (36)

1. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol 2003;54:66-74. (Pubitemid 36764982)
2. Baird AE, Lovblad KO, Schlaug G, Edelman RR, Warach S. Multiple acute stroke syndrome: marker of embolic disease? Neurology 2000;54:674-678. (Pubitemid 30082937)
3. Roh JK, Kang DW, Lee SH, Yoon BW, Chang KH. Significance of acute multiple brain infarction on diffusionweighted imaging. Stroke 2000;31:688-694.
4. Wen HM, Lam WW, Rainer T, et al. Multiple acute cerebral infarcts on diffusion-weighted imaging and risk of recurrent stroke. Neurology 2004;63:1317-1319. (Pubitemid 39350043)
5. Cho AH, Kim JS, Jeon SB, Kwon SU, Lee DH, Kang DW. Mechanism of multiple infarcts in multiple cerebral circulations on diffusion-weighted imaging. J Neurol 2007;254:924-930. (Pubitemid 47222293)
6. Kang DW, Latour LL, Chalela JA, Dambrosia JA, Warach S. Early and late recurrence of ischemic lesion on MRI: evidence for a prolonged stroke-prone state? Neurology 2004;63:2261-2265. (Pubitemid 40024334)
7. Siemonsen S, Mouridsen K, Holst B, et al. Quantitative t2 values predict time from symptom onset in acute stroke patients. Stroke 2009;40:1612-1616.
8. Thomalla G, Rossbach P, Rosenkranz M, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009; 65:724-732.
9. Petkova M, Rodrigo S, Lamy C, et al. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 2010;257:782-792.
10. Sylaja PN, Coutts SB, Subramaniam S, Hill MD, Eliasziw M, Demchuk AM. Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology 2007;68:415-419. (Pubitemid 46208743)
11. Roquer J, Rodriguez-Campello A, Cuadrado-Godia E, et al. Acute brain MRI-DWI patterns and stroke recurrence after mild-moderate stroke. J Neurol 2010;257:947-953.
12. Gurwitz JH, Gore JM, Goldberg RJ, et al. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction: Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med 1998;129:597-604. (Pubitemid 28480814)
13. Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke 2000;31:1802-1811. (Pubitemid 30620454)
14. Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/ American Stroke Association. Stroke 2005;36:916-923.
15. Norris JW, Buchan A, Cote R, et al. Canadian guidelines for intravenous thrombolytic treatment in acute stroke: a consensus statement of the Canadian Stroke Consortium. Can J Neurol Sci 1998;25:257-259. (Pubitemid 28368805)
16. Actilyse. Available at: http://emc.medicines.org.uk/emc/ assets/c/html/displaydoc.asp?documentid-308. Accessed June 10, 2010.
17. Fiehler J, Albers GW, Boulanger JM, et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38:2738-2744. (Pubitemid 47494012)
18. Kakuda W, Thijs VN, Lansberg MG, et al. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005;65:1175-1178. (Pubitemid 41508206)
19. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333:1581-1587.
20. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
21. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41. (Pubitemid 23014379)
22. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
23. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369: 275-282. (Pubitemid 46138121)
24. Hacke W, Kaste M, Fieschi C, et al. Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251. (Pubitemid 28470336)
25. Campbell BC, Christensen S, Butcher KS, et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010;41:82-88.
26. Fiehler J, Siemonsen S, Thomalla G, Illies T, Kucinski T. Combination of T2*W and FLAIR abnormalities for the prediction of parenchymal hematoma following thrombolytic therapy in 100 stroke patients. J Neuroimaging 2009; 19:311-316.
27. Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006;37:2463-2466. (Pubitemid 44454661)
28. Lansberg MG, Thijs VN, Bammer R, et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007;38:2275-2278. (Pubitemid 47457568)
29. Cho AH, Kim JS, Kim SJ, et al. Focal fluid-attenuated inversion recovery hyperintensity within acute diffusionweighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis. Stroke 2008; 39:3424-3426.
30. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003;34:2847-2850. (Pubitemid 37517754)
31. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
32. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-1830. (Pubitemid 40169292)
33. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118.
34. Hill MD, Barber PA, Demchuk AM, Sevick RJ, Frayne R, Buchan AM. Symptomatic hemorrhage after alteplase therapy not due to silent ischemia. BMC Neurol 2001;1:1.
35. Moulin T, Crepin-Leblond T, Chopard JL, Bogousslavsky J. Hemorrhagic infarcts. Eur Neurol 1994;34:64-77. (Pubitemid 24050245)
36. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-1703.